Media Thread, page-1284

IMU will be well and truly in the spotlight I suspect

I'm not sure making the Channel 7 News means much / it might bring a few buyers in
in fact we may get thousands of buyers .....most of whom will bale if they dont get continues gratification .



Today's webinar went a little over my head in some areas .....but I got X 6 Main take away points :

1. The company is still well funded for the foreseeable future

2. IMU is not becoming a CartT company - but using Car T as a vehicle / Combo

3. IMU is a BCell & Oncolyc Virus developer and this deal doesn't dilute that focus

4. The excitement around the Oncolyc Virus combined with Car T technique is very big

5. The speculation is there at even at low dosages once they start trials ( for Toxicity )
Efficacy is likely to be observed & they should have a submission to the FDA prepared shortly

6. The team seemed excited as Billio about the recent news

Note : I am not sure about where the C33 Trials with the FDA fit into the picture ....... does this recent news eclipse that or is it in parallel to .

There is so much going on with this outfit that its easy to lose track of things